期刊文献+

2型糖尿病与高龄老人良性前列腺增生症的关系研究 被引量:7

Relationship between type 2 diabetes mellitus and benign prostatic hyperplasia in elderly patients
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)与高龄老年人良性前列腺增生症(bengn prostatic hyperplasia,BPH)的关系。方法回顾性分析167例高龄BPH患者的临床资料,其中单纯BPH患者64例,T2DM合并BPH患者103例。收集血压、空腹血糖(FBG)、餐后2 h血糖(2 h PBG)、空腹胰岛素(FINS)、糖化血红蛋白(HbAlc)、血脂、血清前列腺特异性抗原(PSA)、国际前列腺症状评分(IPSS)及经腹部超声测量的前列腺体积(PV)等临床资料。结果单纯BPH组和T2DM合并BPH组,两组年龄、合并高血压及高脂血症情况比较,差异无统计学意义(P>0.05);与单纯BPH组相比,BPH合并T2DM组患者血清FINS、PSA、PV水平及IPSS评分显著升高(P<0.05)。BPH合并T2DM组中,不同水平FBG、2 h PBG患者的IPSS评分、PV与血清PSA,差异无统计学意义(P>0.05);BPH合并T2DM组中,HbA1c升高患者与HbA1c正常者比较,IPSS评分、PV与血清PSA明显升高(P<0.05)。结论T2DM是高龄患者BPH发生与进展的危险因素。 Objective To investigate the relationship between(BPH) and type 2 diabetes mellitus(T2DM)in elderly patients.Methods A total of 167 elderly BPH patients were recruited,including 64 cases of non-diabetic BPH and 103 cases of diabetic BPH.The blood pressure and international prostate symptoms score(IPSS)were documented;the prostate volume(PV)was examined by ultrasonography.Glycated hemoglobin(HbA1C),FBG,FINS,blood lipid and serum prostate specific antigen(PSA) were measured.Results There were no differences in age,prevalence of hypertension and hyperlipidemia between non-diabetic BPH and diabetic BPH patients(P0.05).The serum levels of FINS and PSA,PV and IPSS in diabetic BPH patients were higher than those in non-diabetic BPH patients(P0.05).There were no differences in IPSS,PV and PSA at the different levels of FBG and 2h PBG in diabetic BPH patients(P0.05).The level of IPSS,PV and serum PSA in diabetic BPH patients with abnormal HbAlc were higher than those in BPH patients with normal HbAlc(P0.05).Conclusion T2DM might be a risk factor for the onset and development of BPH in elderly patients.
出处 《同济大学学报(医学版)》 CAS 2013年第3期90-93,共4页 Journal of Tongji University(Medical Science)
关键词 良性前列腺增生 2型糖尿病 糖化血红蛋白 老年人 benign prostatic hyperplasia type 2 diabetes mellitus glycated hemoglobin elderly
  • 相关文献

参考文献8

二级参考文献40

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3055
  • 2徐晓峰,王明珠,贺大林,陈兴发,南勋义.手术治疗的良性前列腺增生患者PSA水平增高的相关因素分析[J].陕西医学杂志,2005,34(11):1324-1326. 被引量:3
  • 3卢艳慧,陆菊明,王淑玉,李春霖,刘力生,郑润平,田慧,王先令,杨丽娟,张育青,潘长玉.国际糖尿病联盟与中国糖尿病学会关于代谢综合征诊断标准的比较分析[J].中华医学杂志,2006,86(6):386-389. 被引量:79
  • 4姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 5HammarstenJ, Hogstedt B, Holthuis N, et al. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 1998,1 : 157-162.
  • 6Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007,51 : 199-206.
  • 7Eckel RH,Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet,2005,365 : 1415-1428.
  • 8Kupelian V, Mcvary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol, 2009, 182: 616-625.
  • 9Garraway WM,Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet, 1991,338:469-471.
  • 10Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol,2001,39 : 151-158.

共引文献82

同被引文献38

  • 1那彦群,叶章群,孙光主编.中国泌尿外科疾病诊断治疗指南:人民卫生出版社,2011:417-418.
  • 2D. R. Matthews,J. P. Hosker,A. S. Rudenski,B. A. Naylor,D. F. Treacher,R. C. Turner.Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia . 1985 (7)
  • 3Alan R. Kristal,Kathryn B. Arnold,Jeannette M. Schenk,Marian L. Neuhouser,Noel Weiss,Phyllis Goodman,Colleen M. Antvelink,David F. Penson,Ian M. Thompson.Race/Ethnicity, Obesity, Health Related Behaviors and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial[J]. The Journal of Urology . 2007 (4)
  • 4Wang S,Mao Q,Lin Y,et al.Body mass index and risk of BPH:a meta-analysis. Prostate Cancer and Prostatic Diseases . 2012
  • 5Aruna V. Sarma,Jennifer L. St. Sauver,John M. Hollingsworth,Debra J. Jacobson,Michaela E. McGree,Rodney L. Dunn,Michael M. Lieber,Steven J. Jacobsen.??Diabetes Treatment and Progression of Benign Prostatic Hyperplasia in Community-dwelling Black and White Men(J)Urology . 2012 (1)
  • 6Sara E. Dahle,Anand P. Chokkalingam,Yu-Tang Gao,Jie Deng,Frank Z. Stanczyk,Ann W. Hsing.??Body Size And Serum Levels of Insulin and Leptin in Relation to the Risk of Benign Prostatic Hyperplasia(J)The Journal of Urology . 2002 (2)
  • 7Negami Masako,Takahashi Eiko,Otsuka Hiroki,Moriyama Kengo.Prediction of homeostasis model assessment of insulin resistance in Japanese subjects. The Tokai journal of experimental and clinical medicine . 2012
  • 8Chen Z,Miao L,Gao X,et al.Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes. Int J Clin Exp Med . 2015
  • 9崔师玉,李茵茵,林海燕,车筱琪,王哲,陈海燕.代谢综合征与前列腺体积的相关性[J].中华老年医学杂志,2009,28(7):549-551. 被引量:6
  • 10孟宪琴,屈晓冰,刘颖,刘伟.2型糖尿病与良性前列腺增生症相关性研究进展[J].中国老年学杂志,2011,31(12):2362-2364. 被引量:12

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部